Found 29 matching trials
Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension
PHASE4In patients naive to treatment or after a 2-week washout period for patient...
Location
Multiple Locations
Recurrent Stroke Prevention Clinical Outcome Study
PHASE41. Objectives and Hypothesis
1. Objectives:
This study evaluates...
Location
Jichi Medical Univercity
Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker
PHASE4A comparison of 2 different combinations of high blood pressure medications...
Location
Multiple Locations
Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension
PHASE3This study will evaluate the efficacy and safety of valsartan and amlodipin...
Location
Novartis Investigative Site, , Germany
Renin Profiling in Selection of Initial Antihypertensive Drug
NAThe purpose of this research study is to determine whether a simple blood t...
Location
Lincoln Medical and Mental Health Center
Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients
NAThe Strategy of Blood Pressure Intervention in the Elderly Hypertensive Pat...
Location
Beijing Chaoyang Hospital affiliated to Capical Medical University
Medication Adherence and "True" Resistance in Patients With Resistant Hypertension
N/AThe purpose of this study is to estimate the proportion of patients with "t...
Location
Medical Outpatient Department of the Charité - Universitätsmedizin Berlin
Safety and Efficacy Study of a Triple Combination Therapy in Subjects With Hypertension
PHASE3To determine the effectiveness of four different strength combinations of t...
Location
Multiple Locations
Vascular Improvement With Olmesartan Medoxomil Study
PHASE4The purpose of this study is to compare in patients with primary hypertensi...
Location
Wake Forest University Baptist Medical Center
Lowering Blood Pressure in Primary Care in Vienna
PHASE4The aim of this prospective, randomised, open-label, multicentre clinical t...